FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097819 [Registered on: 21/11/2025] Trial Registered Prospectively
Last Modified On: 12/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of airways devices (I-gel and Endotracheal Tube) on Stomach Volume and Gut Recovery After Laparoscopic abdominal Surgery in Diabetic Patients. 
Scientific Title of Study   Effect of I-gel versus endotracheal intubation on perioperative gastric volume and postoperative gastrointestinal recovery in diabetic patients undergoing laparoscopic abdominal surgeries: a randomized comparative study. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shreya Saxena 
Designation  Junior resident 
Affiliation  Uttar Pradesh University of Medical Sciences 
Address  room 116, rani laxmi bai girls hostel, UPUMS, Saifai, Etawah, Uttar pradesh, India, 206130
UPUMS, Saifai, Etawah
Etawah
UTTAR PRADESH
206130
India 
Phone  9454285194  
Fax    
Email  myselfshreya20@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Usha Shukla 
Designation  Professor and Head 
Affiliation  Uttar Pradesh University of Medical Sciences 
Address  Department of anaesthesiology ,UPUMS

Etawah
UTTAR PRADESH
206130
India 
Phone  9412201915  
Fax    
Email  ushashukla1970@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Usha Shukla 
Designation  Professor and Head 
Affiliation  Uttar Pradesh University of Medical Sciences 
Address  Department of anaesthesiology ,UPUMS

Etawah
UTTAR PRADESH
206130
India 
Phone  9412201915  
Fax    
Email  ushashukla1970@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Uttarpradesh University of medical sciences 
Address  Saifai, Etawah, Uttar Pradesh, 206130 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Shreya Saxena  Uttar Pradesh University of Medical sciences  Department of Anaesthesiology , UPUMS , Saifai , Etawah , Uttar Pradesh
Etawah
UTTAR PRADESH 
9454285194

myselfshreya20@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee, Saifai, UP-206130, Uttar Pradesh University of Medical Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Endotracheal intubation  Direct laryngoscopy will be performed with an appropriate size Macintosh blade and Endotracheal tube (ETT) will be placed. The ETT will then be connected to the anesthesia workstation with previously assigned settings. The tracheal position of the ETT will be confirmed by 5-point auscultation, chest rise, and end tidal carbon dioxide readings. 
Comparator Agent  I-gel  The appropriate size of I-Gel device will be inserted. The placement of I Gel will be confirmed by resistance to further distal movement, end tidal carbon dioxide readings, and effective chest wall movement. If satisfactory insertion is not achieved with three attempts, or there is respiratory embarrassment, the patient will be removed from the study after being intubated via direct laryngoscopy. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.patients undergoing Laproscopic abdominal surgeries
2.Body mass index between 18.5 to 24.9 kg per m2
3.American society of Anaesthesiologists physical status class 2
4.History of Diabetes mellitus for atleast 5 years or more with controlled blood sugar levels.
 
 
ExclusionCriteria 
Details  1. Patient’s refusal
2. Baseline gastric volume more than 1ml per kg on the morning of surgery
3.Diagnosed cases of gastric esophageal reflux disease
4. Anticipated difficult airway
5. Chronic treatment with opioids, steroid, immunosuppresants, chemotherapy, drugs affecting gastric motility or gastric volume
6. Neurological or psychiatric conditions affecting gastric motility
7. Pregnancy 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Comparison of change in perioperative gastric volume using USG guided antral cross sectional area measurement in both the groups.  baseline (preoperative), just after securing airway, and at the end of surgery before extubation. 
 
Secondary Outcome  
Outcome  TimePoints 
Comparison of Postoperative gastrointestinal recovery
 
Time to start clear fluids ( When patient restore atleast 2 bowel sounds per minute).
Time to start Light diet ( When patient restore normal bowel sounds i.e., more than 5 sounds per minute).
Time to First gas discharge ( flatus)
Time to Achieve first bowel movement.
All these parameters will be measured from the time of extubation. 
Measurement of hemodynamic parameters- heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure (MAP).  At baseline (preoperative), just after securing airway, at pneumoperitoneum, and at end of surgery before extubation. 
Measurement of intraoperative ventilatory parameters :Leak volume, leak fraction, Peak airway pressure, Plateau pressure, EtCO2.  Just after securing airway, at pneumoperitoneum, and at end of surgery before extubation 
Degree of gastric distension

 
On insertion of laparoscope. 
Postoperative events
 
In 24 hours after extubation 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study will begin after approval from the Institutional Ethical Committee and registration with the Clinical Trials Registry – India (CTRI). After obtaining informed consent, patients will be randomly assigned to either Group A (endotracheal intubation) or Group B (I-Gel insertion) using a computer-generated random number table and opaque sealed envelopes for allocation concealment. Preoperative assessment will include antral cross-sectional area (CSA) measurement using ultrasound. Standardized general anesthesia will be administered, and airway management will follow group allocation. Ventilation settings will be consistent across groups, and intra-abdominal pressure and Trendelenburg tilt will be maintained as per surgical needs. Data collection will include antral CSA at three time points, hemodynamic parameters, intraoperative ventilatory parameters (leak volume, leak fraction, peak and plateau airway pressures, EtCO2), and gastrointestinal recovery indicators such as time to clear fluids, light diet, flatus, and bowel movement. Gastric distension will be graded by the surgeon using a 5-point Likert scale, and postoperative complications such as nausea, vomiting, and sore throat will be recorded for 24 hours. At the end of surgery, anesthesia will be discontinued and reversal agents administered, with removal of airway devices based on adequate signs of recovery. 
Close